Effects of Anti-HIV Therapy on Nervous System Function

Clinical Trial of Brain-Penetrating HIV Drugs to Prevent Cognitive Impairment in China

NCT01340950 ·Status: COMPLETED ·Phase: PHASE4

Functional Imaging Reserve in NeuroHIV

NCT03596268 ·Status: COMPLETED

HIV-1 Infected Adult Subjects With HIV-associated Neurocognitive Disorders Despite Effective Antiretroviral Therapy

NCT04266002 ·Status: COMPLETED ·Phase: NA

A Study of Dementia and Neurological Problems in HIV Infected Patients Who Are Participating in ACTG A5175

NCT00096824 ·Status: COMPLETED

Neurocognitive Impairment and Psychiatric Comorbidities in HIV-1

NCT00476671 ·Status: COMPLETED

Mental Ability Challenge Study in Adults With and Without HIV

NCT03244488 ·Status: COMPLETED

Assessment of the HIV CNS Reservoir, Neurological and Neuro-cognitive Effects, and Source of Rebound HIV in CNS

NCT02470351 ·Status: COMPLETED

Determining the Prevalence of HIV-Related Neurological Disorders in the Asia Pacific

NCT00168246 ·Status: UNKNOWN

Effect of SwitChing AtriPla to Eviplera on Neurocognitive and Emotional Functioning

NCT02308332 ·Status: COMPLETED ·Phase: PHASE4

Central Nervous System Disease in HIV-infected Children on HAART

NCT00110331 ·Status: COMPLETED

SV2A & TSPO PET Imaging Measures to Reveal Mechanisms of HIV Neuropathogenesis During Antiretroviral Therapy

NCT05586581 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

HIV Levels in Cerebrospinal Fluid and Brain Function in Patients Receiving Anti-HIV Drugs

NCT00001103 ·Status: COMPLETED

Changes in Cerebral Function in Treatment Naive HIV-1 Infected Subjects Commencing Either Boosted Atazanavir With Truvada or Boosted Darunavir With Maraviroc and Kivexa

NCT01367236 ·Status: COMPLETED ·Phase: PHASE4

A Study of the Long-Term Outcomes of HIV-Positive Patients

NCT00000932 ·Status: COMPLETED

Effects of Diet on Brain Processing

NCT02835820 ·Status: COMPLETED ·Phase: NA

The CogNaive Study: Assessing Changes in Neurocognitive Function in Treatment Naïve HIV-1 Positive Subjects

NCT00540137 ·Status: COMPLETED ·Phase: PHASE4

Teleneuropsychological Intervention in Asymptomatic HIV Seropositive Patients: N&C NeuroChange

NCT05571761 ·Status: WITHDRAWN ·Phase: NA

Predictors of Neuro-cognitive Decline and Survival in HIV-infected Subjects

NCT00864292 ·Status: COMPLETED

Evaluation of a Short Version Computerized Test for Processing Speed to Detect Cognitive Disorders in HIV+ Patients

NCT03279835 ·Status: COMPLETED

Ferumoxytol-enhanced Brain MRI in HIV-associated Neurocognitive Disorders

NCT01665846 ·Status: COMPLETED ·Phase: PHASE1

HIV Medication Adherence in Underserved Populations

NCT02392884 ·Status: UNKNOWN ·Phase: NA

Comparison of Anti HIV Drugs Used Alone or in Combination With Cytosine Arabinoside to Treat Progressive Multifocal Leukoencephalopathy (PML) in HIV-Infected Patients

NCT00001048 ·Status: COMPLETED ·Phase: PHASE2

Assessment of Attentional Functioning in Children With HIV-1 Infection

NCT00001497 ·Status: COMPLETED

Prevalence, Characteristics and Risk Factors of HIV-Associated Neurocognitive Disorders in Subjects Between the Ages of 55 and 70 Years: An Exposed/Unexposed Cross Sectional Study

NCT02592174 ·Status: COMPLETED ·Phase: NA

Long Term Follow-Up of HIV Infected Patients Who Have Previously Participated in HIV Clinical Trials

NCT00183287 ·Status: COMPLETED